Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Invenra & Catalent Team Up to Develop Next-Gen Cancer Therapies | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Invenra & Catalent Team Up to Develop Next-Gen Cancer Therapies

Aim to harness the combined expertise and proprietary technologies of both companies to co-discover novel bispecific antibody-drug conjugates.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Invenra Inc., a leader in bispecific antibody technology, has entered a strategic collaboration with Catalent, a global Contract Development and Manufacturing Organization (CDMO) specializing in drug development solutions, which aims to harness the combined expertise and proprietary technologies of Invenra and Catalent to co-discover novel bispecific antibody-drug conjugates.
 
Dr. Roland Green, CEO of Invenra, remarks, “We are excited to collaborate with the innovative team at Catalent’s Redwood Bioscience subsidiary. We believe that the combination of Invenra’s B-Body bispecific antibody platform with Catalent’s SMARTag ADC expertise has the potential to unlock synergies and accelerate the development of next-generation cancer therapeutics.”
 
Both companies share a commitment to developing novel therapeutic solutions with the potential to make a meaningful impact in the lives of patients.
 
This news comes months after Catalent Inc. and Novo Holdings entered into a merger agreement under which Novo Holdings agreed to acquire Catalent.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics